Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3 - Mural Oncology

8th May 2025 11:53

RNS Number : 9143H
Goldman Sachs & Co. LLC
08 May 2025
 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

Name of person dealing (Note 1)

GOLDMAN SACHS & CO. LLC

Company dealt in

MURAL ONCOLOGY PLC

Class of relevant security to which the dealings being disclosed relate (Note2)

USD 0.01 ordinary shares

Date of dealing

07 May 2025

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in  (Note 3)

 

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

90,971

(0.52)

183,666

(1.06)

(2) Derivatives (other than options)

89,372

(0.51)

0

(0.00)

(3) Options and agreements to purchase/sell

0

(0.00)

0

(0.00)

Total

180,343

(1.04)

183,666

(1.06)

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in  (Note 3)

 

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

 

3. DEALINGS (Note 4)

(a) Purchases and sales

 

Purchase/sale

Number of relevant securities

Price per unit  (Note 5)

Purchase

1

2.5250 USD

 

(b) Derivatives transactions (other than options transactions)

 

Product name, e.g. CFD

Nature of transaction  (Note 6)

Number of relevant securities  (Note 7)

Price per unit  (Note 5)

 

(c) Options transactions in respect of existing relevant securities

 

(i) Writing, selling, purchasing or varying

 

Product name,e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates  (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit  (Note 5)

 

(ii) Exercising

 

Product name,e.g. call option

Number of securities

Exercise price per unit  (Note 5)

 

(d) Other dealings (including transactions in respect of new securities)  (Note 4)

 

Nature of transaction  (Note 8)

Details

Price per unit (if applicable)  (Note 5)

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. 

NONE

 

Is a Supplemental Form 8 attached? (Note 9) YES

 

Date of disclosure

08 May 2025

Contact name

Papa Lette and Andrzej Szyszka

Telephone number

+33(1) 4212 1459 / +48(22) 317 4817

If a connected EFM, name of offeree/offeror with which connected

If a connected EFM, state nature of connection (Note 10)

 

SUPPLEMENTAL FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DETAILS OF OPEN POSITIONS

OPEN POSITIONS (Note 1)

 

Product name,e.g. call option

Written or purchased

Number of relevant securities to which the option or derivative relates

Exercise price (Note 2)

Type, e.g. American, European etc.

Expiry date

Swap

Purchased

1

0.0000

N/A

08/07/2025

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ITPBVLFBEELEBBX
FTSE 100 Latest
Value8,561.40
Change29.79